We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Biotech's wellspring: the health of private biotech in 2013.
- Authors
Huggett, Brady
- Abstract
The article discusses the growth of biotechnology in public markets in the U.S., along with the concern on whether the boom of biotechnology in public sector will resonate in the private sector. Topics discussed include the biotechnology initial public offering (IPO) market, the funding of biotechnology start-ups, and the case of biotechnology company Intrexon as one of the private biotechnology companies which took largest venture capital (VC) rounds in 2013.
- Subjects
BIOTECHNOLOGY; BIOTECHNOLOGY industries; PUBLIC sector; PRIVATE sector; GOING public (Securities); INTREXON Corp.; NEW business enterprises; VENTURE capital
- Publication
Nature Biotechnology, 2014, Vol 32, Issue 5, p428
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt.2905